- Home
- DHIL vs AURA Comparison
DHIL vs AURA Comparison
Compare DHIL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- AURA
- Stock Information
- Founded
- DHIL 1990
- AURA 2007
- Country
- DHIL United States
- AURA United States
- Employees
- DHIL N/A
- AURA N/A
- Industry
- DHIL Investment Managers
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- DHIL Finance
- AURA Health Care
- Exchange
- DHIL Nasdaq
- AURA Nasdaq
- Market Cap
- DHIL 370.3M
- AURA 370.1M
- IPO Year
- DHIL 1995
- AURA 2021
- Fundamental
- Price
- DHIL $138.69
- AURA $6.07
- Analyst Decision
- DHIL
- AURA Strong Buy
- Analyst Count
- DHIL 0
- AURA 5
- Target Price
- DHIL N/A
- AURA $22.60
- AVG Volume (30 Days)
- DHIL 13.9K
- AURA 243.7K
- Earning Date
- DHIL 04-29-2025
- AURA 05-15-2025
- Dividend Yield
- DHIL 4.25%
- AURA N/A
- EPS Growth
- DHIL 0.69
- AURA N/A
- EPS
- DHIL 14.79
- AURA N/A
- Revenue
- DHIL $151,916,411.00
- AURA N/A
- Revenue This Year
- DHIL N/A
- AURA N/A
- Revenue Next Year
- DHIL N/A
- AURA N/A
- P/E Ratio
- DHIL $9.55
- AURA N/A
- Revenue Growth
- DHIL 9.28
- AURA N/A
- 52 Week Low
- DHIL $122.32
- AURA $4.35
- 52 Week High
- DHIL $173.25
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- DHIL 48.40
- AURA 53.26
- Support Level
- DHIL $140.71
- AURA $5.68
- Resistance Level
- DHIL $144.68
- AURA $6.30
- Average True Range (ATR)
- DHIL 2.32
- AURA 0.46
- MACD
- DHIL -0.25
- AURA 0.05
- Stochastic Oscillator
- DHIL 35.42
- AURA 78.97
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.